Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Blog

Perma-Pipe's Q4 Earnings Increase Y/Y on Volume Growth
Perma-Pipe's Q4 Earnings Increase Y/Y on Volume Growth

Shares of Perma-Pipe International Holdings, Inc. PPIH have declined 12.4% since the company reported its earnings for the quarter ended Jan. 31, 2026, underperforming the S&P 500 index’s 1.1%

Welltower Gears Up to Report Q1 Earnings: What's in the Cards?
Welltower Gears Up to Report Q1 Earnings: What's in the Cards?

Welltower, Inc. WELL is slated to report first-quarter 2026 results on April 28, after market close. The quarterly results are likely to reflect year-over-year growth in revenues and normalized

Avantor Expands Masterflex Portfolio to Streamline Bioprocessing
Avantor Expands Masterflex Portfolio to Streamline Bioprocessing

Avantor, Inc. AVTR recently announced a strategic expansion of its Masterflex brand across its fluid handling portfolio. The expansion integrates standard, configurable and engineered-to-order

Do Options Traders Know Something About Sprout Social Stock We Don't?
Do Options Traders Know Something About Sprout Social Stock We Don't?

Investors in Sprout Social, Inc. SPT need to pay close attention to the stock based on moves in the options market lately. That is because the July 17, 2026 $17.50 Call had some of the highest

OCGN Gene Therapy Pipeline: Key 2026-27 Catalysts Ahead
OCGN Gene Therapy Pipeline: Key 2026-27 Catalysts Ahead

Ocugen OCGN is advancing three one-time gene therapy programs for retinal diseases, each aimed at conditions with large unmet needs and limited effective options.

The company’s late-stage calendar

Ocugen Stock Outlook: Valuation, Cash Runway and Dilution Risk
Ocugen Stock Outlook: Valuation, Cash Runway and Dilution Risk

Ocugen OCGN is advancing a late-stage ophthalmology pipeline built around one-time gene therapies for retinal diseases with large unmet needs. Multiple clinical readouts and regulatory milestones

OCGN's Gene-Agnostic Strategy Could Reset Retinal Therapy
OCGN's Gene-Agnostic Strategy Could Reset Retinal Therapy

Ocugen OCGN is pushing a modifier gene therapy platform across several retinal diseases where current options are limited, burdensome, or simply absent. The common thread is a “gene-agnostic”

Nebius vs. Oracle: Which AI Cloud Stock Is the Better Buy?Photo, wide shot, wide-angle lens,  Semiconductor company, sunset photo at golden hour, photo by Art Wolfe: https://img.midjourneyapi.xyz/temp/92ce44e9-64c7-4458-9a95-b706ed510490.png
Nebius vs. Oracle: Which AI Cloud Stock Is the Better Buy?

Nebius Group N.V. NBIS and Oracle Corporation ORCL are emerging as compelling contenders in the rapidly evolving AI cloud market, though they approach the opportunity from fundamentally different

AG vs. HL: Which Silver Mining Stock Has Greater Upside Now?Photo, wide shot, wide-angle lens,  Coal mine, Midday, harsh overhead sunlight, directional sunlightt, photo by Thomas Heaton: https://img.midjourneyapi.xyz/temp/25526de2-54da-40ae-ba56-1e25dead3e81.png
AG vs. HL: Which Silver Mining Stock Has Greater Upside Now?

First Majestic Silver Corp. AG and Hecla Mining Company HL are both prominent names operating in the Zacks Mining - Silver industry. As competitors, these two are focused on extracting and operating

Earnings Estimates Moving Higher for State Street (STT): Time to Buy?
Earnings Estimates Moving Higher for State Street (STT): Time to Buy?

Investors might want to bet on State Street Corporation (STT), as earnings estimates for this company have been showing solid improvement lately. The stock has already gained solid short-term price

Why Private Bancorp of America (PBAM) Might be Well Poised for a Surge
Why Private Bancorp of America (PBAM) Might be Well Poised for a Surge

Private Bancorp of America, Inc. (PBAM) could be a solid choice for investors given the company's remarkably improving earnings outlook. While the stock has been a strong performer lately, this

Implied Volatility Surging for Option Care Health Stock Options
Implied Volatility Surging for Option Care Health Stock Options

Investors in Option Care Health, Inc. OPCH need to pay close attention to the stock based on moves in the options market lately. That is because the July 17, 2026 $25.00 Call had some of the highest

Netflix's Engagement Momentum Builds: Is Growth Sustainable?
Netflix's Engagement Momentum Builds: Is Growth Sustainable?

Netflix’s NFLX engagement momentum is strengthening, raising confidence in the sustainability of its growth. The company reported a record high in its primary engagement quality metric in the first

MRK Down as Triplet Therapy Fails to Meet Goal in Kidney Cancer Study
MRK Down as Triplet Therapy Fails to Meet Goal in Kidney Cancer Study

Merck MRK, along with its partner Eisai, announced that the phase III LITESPARK-012 study, which evaluated Keytruda-based triplet regimens for the first-line treatment of patients with advanced

Important Factors to Watch Ahead of BP's Q1 Earnings Release
Important Factors to Watch Ahead of BP's Q1 Earnings Release

BP plc BP is set to report first-quarter 2026 results on April 28, 2026.

In the last reported quarter, the British energy giant reported earnings of 60 cents per American Depositary Share (“ADS”) on

Will Marex Group PLC (MRX) Beat Estimates Again in Its Next Earnings Report?
Will Marex Group PLC (MRX) Beat Estimates Again in Its Next Earnings Report?

Looking for a stock that has been consistently beating earnings estimates and might be well positioned to keep the streak alive in its next quarterly report? Marex Group PLC (MRX), which belongs to

Will MarketAxess (MKTX) Beat Estimates Again in Its Next Earnings Report?
Will MarketAxess (MKTX) Beat Estimates Again in Its Next Earnings Report?

If you are looking for a stock that has a solid history of beating earnings estimates and is in a good position to maintain the trend in its next quarterly report, you should consider MarketAxess

Why Lincoln Electric (LECO) is Poised to Beat Earnings Estimates Again
Why Lincoln Electric (LECO) is Poised to Beat Earnings Estimates Again

Have you been searching for a stock that might be well-positioned to maintain its earnings-beat streak in its upcoming report? It is worth considering Lincoln Electric Holdings (LECO), which belongs

Why L3Harris (LHX) is Poised to Beat Earnings Estimates Again
Why L3Harris (LHX) is Poised to Beat Earnings Estimates Again

Looking for a stock that has been consistently beating earnings estimates and might be well positioned to keep the streak alive in its next quarterly report? L3Harris (LHX), which belongs to the

Can Merchants Bancorp (MBIN) Keep the Earnings Surprise Streak Alive?
Can Merchants Bancorp (MBIN) Keep the Earnings Surprise Streak Alive?

Looking for a stock that has been consistently beating earnings estimates and might be well positioned to keep the streak alive in its next quarterly report? Merchants Bancorp (MBIN), which belongs

Will Lundin (LUNMF) Beat Estimates Again in Its Next Earnings Report?Photo, wide shot, wide-angle lens,  Gold mine, Midday, harsh overhead sunlight, directional sunlightt, photo by Thomas Heaton: https://img.midjourneyapi.xyz/temp/94faf2bd-99c1-4ea6-b55d-fdcab23c3865.png
Will Lundin (LUNMF) Beat Estimates Again in Its Next Earnings Report?

Looking for a stock that has been consistently beating earnings estimates and might be well positioned to keep the streak alive in its next quarterly report? Lundin Mining (LUNMF), which belongs to

Will Markel Group (MKL) Beat Estimates Again in Its Next Earnings Report?
Will Markel Group (MKL) Beat Estimates Again in Its Next Earnings Report?

Have you been searching for a stock that might be well-positioned to maintain its earnings-beat streak in its upcoming report? It is worth considering Markel Group (MKL), which belongs to the Zacks

Why Lear (LEA) is Poised to Beat Earnings Estimates Again
Why Lear (LEA) is Poised to Beat Earnings Estimates Again

Have you been searching for a stock that might be well-positioned to maintain its earnings-beat streak in its upcoming report? It is worth considering Lear (LEA), which belongs to the Zacks

Will Crescent Energy (CRGY) Beat Estimates Again in Its Next Earnings Report?
Will Crescent Energy (CRGY) Beat Estimates Again in Its Next Earnings Report?

Looking for a stock that has been consistently beating earnings estimates and might be well positioned to keep the streak alive in its next quarterly report? Crescent Energy (CRGY), which belongs to

Why Cheesecake Factory (CAKE) is Poised to Beat Earnings Estimates Again
Why Cheesecake Factory (CAKE) is Poised to Beat Earnings Estimates Again

Looking for a stock that has been consistently beating earnings estimates and might be well positioned to keep the streak alive in its next quarterly report? Cheesecake Factory (CAKE), which belongs